BCI Marketplace
Depression Neuromodulation trials

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

RecruitingNCT07642882Phase: NAStarted 2026-09

Summary

Repetitive Transcranial Magnetic Stimulation (rTMS) of the motor cortex is a recognized analgesic technique for the treatment of fibromyalgia pain, which represents a largely unmet medical need. However, the effectiveness of motor cortex rTMS is inconsistent, being observed in only about 40% of patients and not always long-lasting. It has been previously shown that predictive factors for a lack of response to motor cortex rTMS include the presence of depressive symptoms, and that prefrontal cort

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
80 Years

Inclusion Criteria: * Chronic pain lasting at least 6 months, with or without associated depressive symptoms; * Fibromyalgia (2016 revised ACR criteria and a FIRST questionnaire score of at least 5 out of 6); * Average pain intensity ≥ 4/10 on a 0-10 numeric rating scale; * Pain present daily or al

Locations

Hopital Ambroise-Paré INSERM U987, 9 Av. Charles de Gaulle
Boulogne-Billancourt, Île-de-France Region, France

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →